Pharmaceutical composition and application thereof

A composition and drug technology, applied in the direction of drug combination, application, active ingredients of hydroxyl compounds, etc., can solve problems such as sugar decomposition and absorption disorders, increased bacterial fermentation gas production, intestinal gas, etc., to achieve good results and less side effects low effect

Active Publication Date: 2013-05-22
HILL PHARMA
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this type of drug causes the decomposition and absorption of sugar in the intestinal tract, and the residence time is prolonged, which ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition and application thereof
  • Pharmaceutical composition and application thereof
  • Pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Determination of the inhibitory activity of 1-deoxynojirimycin and resveratrol on α-D-glucosidase

[0025] Add 80 μL of sample aqueous solution (sample group) or phosphate buffer solution (control group) into the holes of the 96-well plate according to different groups as shown in Table 1, and add 40 μL of substrate solution (20×10 -3 mol / L p-nitrophenyl-α-D-glucopyranoside (PNPG)), mixed well and placed in a 37°C water bath for pre-incubation for 5 min, then added 40 μL mouse intestinal enzyme initial extract (accurately weighed 100 mg Add rat intestine acetone powder to 1mL 0.9% normal saline, dissolve it by ultrasonic treatment (1 min×3), centrifuge at 3000r / min for 30min, take out the supernatant and dilute it 4 times with distilled water, store it at 4°C for future use), and store it at 37°C After reacting for 15 min, add 0.2 mol / L Na 2 CO 3 160 μL of solution was used to stop the reaction, and the absorbance was measured at 405 nm with a microplate reader. The ...

Embodiment 2

[0034] Effects of Different Dosage Compositions on Blood Glucose in Spontaneously Hyperglycemic Mice

[0035] 1. Drugs: 1-deoxynojirimycin, resveratrol, self-made, prepared to the required concentration with distilled water before the test (the sum of the concentrations of 1-deoxynojirimycin and resveratrol in the composition is the same as the concentration of the prepared white same concentrations of veratrol or 1-deoxynojirimycin). Baitangping, Bayer Pharmaceuticals and Healthcare Co., Ltd.

[0036] 2. Animals: NOD mice, weighing 25-35 g, were purchased from the Experimental Animal Center of Peking University Health Science Center. Blood glucose was measured before the experiment, and animals whose blood glucose value was higher than 11.1mmol / L were selected for the experiment.

[0037] 3. Test methods and results

[0038] Effects on blood glucose in mice: NOD mice were fasted for 6 hours, and blood glucose was measured, and 80 animals with blood glucose values ​​hig...

Embodiment 3

[0045] Effects of Different Dosage Composition on Gastrointestinal Propulsion in Mice

[0046] 1. Experimental animals

[0047] Kunming mice, clean grade, weighing 20g-22g

[0048] 2. experimental method

[0049] 60 Kunming mice fasted for 12 hours were randomly divided into 6 groups according to body weight. After fasting for 18 hours, the following drugs were given by intragastric administration: ① control group (distilled water); ② acarbose group (10mg / kg) 3.-6. Compositions of different proportions (10mg / kg, different drug ratios, the same total amount), after 15min, each mouse was given 0.2ml of 5% charcoal gum arabic suspension by intragastric administration. Shake the 5% charcoal gum arabic suspension vigorously. 20 minutes after gavage with powdered charcoal, the mice were sacrificed by dislocation, the abdominal cavity was opened, and the gastrointestinal tract was taken out. Cut off the mesentery attached to the intestinal tube, and gently spread the intestinal ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition, and in particular discloses a pharmaceutical composition for treating diabetes and complications thereof. The pharmaceutical composition consists of 1-deoxynojirimycin (1-DNJ for short) and resveratrol, wherein weight ratio of the 1-DNJ to the resveratrol is (1-5):15. The medicine disclosed by the invention can effectively inhibit alpha-glucosidase and reduce blood sugar concentration, and is more excellent in effect and lower in side effect in comparison with a simple blood sugar reducing compound; the pharmaceutical composition can be used for preparing blood sugar reducing medicines, food or healthcare products, as well as medicines, food or healthcare products for preventing or treating complications of diabetes.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating diabetes and its complications. Background technique [0002] Diabetes mellitus (DM) is a syndrome characterized by persistent hyperglycemia. It is mainly due to the disorder of glucose metabolism caused by relative or absolute insulin deficiency. In recent years, the incidence of diabetes has been increasing year by year, and it has become the third serious chronic disease after tumor and cardiovascular disease. If diabetic patients do not take hypoglycemic treatment in time, it can lead to chronic complications in tissues and organs such as eyes, kidneys, nerves, blood vessels and heart, and eventually lead to insomnia, lower limb gangrene, uremia, stroke or myocardial infarction. [0003] Alpha-glucosidase is an enzyme that breaks down unabsorbed complex carbohydrates into simple sugars that can be absorbed in the small intestine. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/445A61K31/05A61P3/10A61P13/12A23L1/30
Inventor 周阳峰
Owner HILL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products